Drug intelligence / Profile preview

iron-carbon nanoparticles

Development stage
Preclinical
Lead developer
Ahmed El Gendy
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intratumoral
01

Overview

Iron-carbon (Fe/C) nanoparticles, also referred to as SPINs in research contexts, are magnetic nanoparticles engineered for magnetic hyperthermia-based cancer therapy. These nanoparticles are synthesized using a co-precipitation method with optimized precursor ratios to achieve a high saturation magnetization (e.g., 148.6 emu/g). The therapeutic mechanism involves the intratumoral administration of the nanoparticles followed by exposure to an alternating magnetic field (AMF). The AMF causes the nanoparticles to generate localized heat, which induces thermal-mediated cell death (hyperthermia) in the tumor tissue. Preclinical studies in breast cancer (MCF-7) and prostate cancer (DU145) xenograft models have demonstrated that these nanoparticles can induce significant tumor reduction and near-complete regression, depending on the dosage and field exposure.

Other names
Fe/C nanoparticlesiron-carbon SPINsoptimized iron-carbon nanoparticles

Beyond the preview

Go deeper on iron-carbon nanoparticles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iron-carbon nanoparticles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call